{
  "type": "analysis_section_rewrite",
  "timestamp": "2025-08-23T23:18:07",
  "processed": false,
  "inputs": {
    "topic_id": "us_10y",
    "section": "medium",
    "test": "False",
    "run_id": "us_10y__analysis_run__1755983576",
    "article_ids": "['SK994CBWR', 'FOM34PUWA', '3JR35PMNT', 'SK994CBWR', 'FOM34PUWA']",
    "selected_articles_count": "5",
    "material_chars": "107748",
    "output_chars": "1774",
    "saved": "True",
    "saved_field": "medium_analysis",
    "status": "success"
  },
  "details": {
    "llm": {
      "model": "openai/gpt-oss-20b",
      "feedback": "**Actionable edit checklist (compact paragraph)**  \n1. **Add citations** – every key figure (Q2 revenue $215 m, net income $30 m, EPS $1.75, gross margin 49.4 %, debt‑to‑equity 23.3 %, 2025 revenue guidance $850‑$950 m) must reference the source ID SK994CBWR.  \n2. **Quantify macro drivers** – include the Fed’s projected rate‑cut window (Q4 2025) and the CHIPS Act’s 2025‑2026 funding tranche (≈$52 bn) to anchor the “Fed‑dovish” and “US‑semiconductor‑policy” triggers.  \n3. **Build a 3‑step scenario map** – (a) Base: Q3 earnings beat, modest Fed cut → 10‑15 % upside to $35.5 (b) Bull: export‑control easing + CHIPS funding → 20‑25 % rally to $39‑$40 (c) Bear: Fed hike or renewed US‑China tension → 10‑15 % downside to $28.  \n4. **Specify path‑dependency** – note that the N2‑bubbling rollout is contingent on securing ≥ 30 % of the 2025 fab‑order pipeline; delay in large‑fab contracts would stall the 10‑15 % upside.  \n5. **Add watch‑list signals** – Fed minutes (Oct 2025), US‑China trade‑policy updates, CHIPS Act funding announcements, and ACMR’s Q3 guidance release (mid‑Oct 2025).  \n6. **Re‑frame risk language** – replace generic “geopolitical uncertainty” with concrete risks: (i) export‑control tightening (ii) US‑China tariff escalation (iii) Fed rate hike.  \n7. **Improve clarity & depth** – remove vague “high gross margin” phrasing; instead state “gross margin 49.4 % (SK994CBWR) vs industry 45 %.”  \n8. **Align with horizon** – keep all catalysts and triggers within the 3–6 month window; avoid long‑term speculation.  \n9. **Add confidence rating** – state “moderate‑high confidence (70 %)” with justification (strong earnings quality, low debt, macro tailwinds).  \n10. **Ensure source coverage** – cross‑check that all critical sources (SK994CBWR, 3JR35PMNT for dividend context, FOM34PUWA for macro‑policy backdrop) are cited; reconcile any conflicting revenue guidance figures.  \n\nImplementing these edits will elevate the analysis to world‑class quality, ensuring depth, specificity, and rigorous source backing.",
      "tokens": {}
    }
  },
  "id": "us_10y__medium__us_10y__analysis_run__1755983576"
}